Looking forward to (nearly all of) our Thalocan Research Innovations Team meeting friends old and new at SHSA 2025 in Nashville, where we are a proud Bronze Sponsor! We have put a great deal of time and energy towards solutions to improve data quality, as well as patient experience and Investigator satisfaction. SHSA 2025 will…
Dr. Amit Garg shares his experience with the unique challenges of disease assessment and measuring treatment response in Hidradenitis Suppurativa. At Thalocan Research Innovations we collaborate with experts like Dr. Garg and Dr. John Ingram, among others, to develop tools and applications that improve the experience for trialists and patients, as well as optimizing the…
We are grateful to Dr. Steve Daveluy for his comments regarding trainings provided by Thalocan Research Innovations, including our Hidradenitis Suppurativa Clinical Trial training led by Dr. Amit Garg and Dr. John Ingram. You can view a portion of that here or learn about our other training curriculums by visiting www.thalocan.com/trainings
More than 204 million people worldwide (or 2.6% of the world’s population) experience eczema. During October, we here at Thalocan Research Innovations are honored to join health organizations and dermatology groups work to continue to educate the public on eczema and reduce the stigma surrounding this chronic inflammatory skin condition. Of special note is the…
